The Secretary of Defense, and the Secretary of Homeland Security with respect to the Coast Guard when it is not operating as a service in the Navy, shall prescribe regulations, implement procedures using each practical and available method, and provide necessary facilities to identify, treat, and rehabilitate members of the armed forces who are dependent on drugs or alcohol.
Open TableRevised section | Source (U.S. Code) | Source (Statutes at Large) |
---|---|---|
1090 | 10:1071 (note). | Sept. 28, 1971, Pub. L. 92–129, §501(a)(1), 85 Stat. 361. |
The word "regulations" is added for consistency. The word "persons" is omitted as surplus.
Amendments
2002—Pub. L. 107–296 substituted "of Homeland Security" for "of Transportation".
1990—Pub. L. 101–510 inserted ", and the Secretary of Transportation with respect to the Coast Guard when it is not operating as a service in the Navy," after "Secretary of Defense".
1983—Pub. L. 98–94 struck out "(a)" before "The Secretary of Defense".
Effective Date of 2002 Amendment
Amendment by Pub. L. 107–296 effective on the date of transfer of the Coast Guard to the Department of Homeland Security, see section 1704(g) of Pub. L. 107–296, set out as a note under section 101 of this title.
Pilot Program on Opioid Management in the Military Health System
Pub. L. 115–232, div. A, title VII, §716, Aug. 13, 2018, 132 Stat. 1814, provided that:
"(a)
"(1)
"(2)
"(b)
"(1) Identification of potential misuse or abuse of opioid medications in pharmacies of military treatment facilities, retail network pharmacies, and the home delivery pharmacy, and the transmission of alerts regarding such potential misuse or abuse of opioids to prescribing physicians and dentists.
"(2) Direct engagement with, education for, and management of beneficiaries under the TRICARE program to help such beneficiaries avoid misuse or abuse of opioid medications.
"(3) Proactive outreach by specialist pharmacists to beneficiaries under the TRICARE program when identifying potential misuse or abuse of opioid medications.
"(4) Monitoring of beneficiaries under the TRICARE program through the use of predictive analytics to identify the potential for opioid abuse and addiction before beneficiaries begin an opioid prescription.
"(5) Detection of fraud, waste, and abuse in connection with opioids.
"(c)
"(1)
"(2)
"(d)
"(1)
"(2)
"(A) A description of the pilot program, including outcome measures developed to determine the overall effectiveness of the mechanisms under the pilot program.
"(B) A description of the ability of the mechanisms under the pilot program to identify misuse and abuse of opioid medications among beneficiaries under the TRICARE program in each pharmacy venue of the pharmacy program of the military health system.
"(C) A description of the impact of the use of predictive analytics to monitor beneficiaries under the TRICARE program in order to identify the potential for opioid abuse and addiction before beneficiaries begin an opioid prescription.
"(D) A description of any reduction in the misuse or abuse of opioid medications among beneficiaries under the TRICARE program as a result of the pilot program.
"(e)